SCHEMBL6356729

SCHEMBL6356729

CCc1cc(C(C)(C)C)c([O-])c(C(C)(C)C)c1.C[Al+]C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 1/20 0.47
ALDH1A1 P00352 6/20 0.33
TSHR P16473 3/20 0.33
LMNA P02545 2/20 0.33
GAA P10253 1/20 0.33
CYP1A2 P05177 3/20 0.32
MAPK1 P28482 3/20 0.32
MEN1 O00255 2/20 0.32
CYP3A4 P08684 2/20 0.32
BLM P54132 2/20 0.32
KMT2A Q03164 2/20 0.32
ATM Q13315 2/20 0.32
HIF1A Q16665 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
ALOX15 P16050 2/20 0.32
GMNN O75496 1/20 0.32
GABBR2 O75899 1/20 0.32
TP53 P04637 1/20 0.32
CYP2C9 P11712 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6039744 0.89 HSPA5 (0.48) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL6349436 0.89 HSPA5 (0.48) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL6356731 0.76 GABRA1 (0.37) ALDH1A1TSHRLMNACYP1A2CYP3A4
Butylated Hydroxytoluene SCHEMBL2162145 0.76 ALDH1A1 (0.50) HSPA5ALDH1A1TSHRLMNACYP1A2
SCHEMBL25477939 0.73 HSPA5 (0.53) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL2177579 0.73 HSPA5 (0.53) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL11549682 0.72 ALDH1A1 (0.34) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL39434 0.71 HSPA5 (0.74) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL1930161 0.71 HSPA5 (0.52) HSPA5ALDH1A1TSHRLMNAGAA
SCHEMBL28409879 0.70 HSPA5 (0.50) HSPA5ALDH1A1TSHRLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070542-A1 5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds NEUROGEN CORPORATION 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070542-A1 5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds CRHR1, HTR5A, HTR1D HSPA5 1050/4885ALDH1A1 1664/4885TSHR 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.